Disturbed flow-induced Gs-mediated signaling protects against endothelial inflammation and atherosclerosis.
Adrenomedullin
/ metabolism
Animals
Atherosclerosis
/ pathology
Blood Circulation
/ physiology
Calcitonin Receptor-Like Protein
/ metabolism
Cattle
Cell Adhesion Molecules
/ metabolism
Endothelial Cells
/ metabolism
Endothelium, Vascular
/ metabolism
Human Umbilical Vein Endothelial Cells
/ cytology
Humans
Inflammation
/ metabolism
Mice
NF-kappa B
/ metabolism
Primary Cell Culture
Signal Transduction
Vascular Cell Adhesion Molecule-1
/ metabolism
Atherosclerosis
G-proteins
Inflammation
Vascular Biology
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
03 12 2020
03 12 2020
Historique:
received:
21
05
2020
accepted:
28
10
2020
entrez:
3
12
2020
pubmed:
4
12
2020
medline:
25
5
2021
Statut:
epublish
Résumé
Atherosclerosis develops preferentially in areas of the arterial system, in which blood flow is disturbed. Exposure of endothelial cells to disturbed flow has been shown to induce inflammatory signaling, including NF-κB activation, which leads to the expression of leukocyte adhesion molecules and chemokines. Here, we show that disturbed flow promotes the release of adrenomedullin from endothelial cells, which in turn activates its Gs-coupled receptor calcitonin receptor-like receptor (CALCRL). This induces antiinflammatory signaling through cAMP and PKA, and it results in reduced endothelial inflammation in vitro and in vivo. Suppression of endothelial expression of Gαs, the α subunit of the G-protein Gs; CALCRL; or adrenomedullin leads to increased disturbed flow-induced inflammatory signaling in vitro and in vivo. Furthermore, mice with induced endothelial-specific deficiency of Gαs, CALCRL, or adrenomedullin show increased atherosclerotic lesions. Our data identify an antiinflammatory signaling pathway in endothelial cells stimulated by disturbed flow and suggest activation of the endothelial adrenomedullin/CALCRL/Gs system as a promising approach to inhibit progression of atherosclerosis.
Identifiants
pubmed: 33268595
pii: 140485
doi: 10.1172/jci.insight.140485
pmc: PMC7714404
doi:
pii:
Substances chimiques
CALCRL protein, human
0
Calcitonin Receptor-Like Protein
0
Cell Adhesion Molecules
0
NF-kappa B
0
Vascular Cell Adhesion Molecule-1
0
Adrenomedullin
148498-78-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Physiol Rev. 2009 Apr;89(2):481-534
pubmed: 19342613
Circ Res. 2010 Jun 11;106(11):1703-11
pubmed: 20378855
Cell Mol Life Sci. 2011 Dec;68(23):3823-41
pubmed: 21744067
Hypertension. 1997 Jun;29(6):1296-302
pubmed: 9180632
Peptides. 2008 Jan;29(1):73-8
pubmed: 18054815
Nat Cell Biol. 2016 Oct;18(10):1043-53
pubmed: 27595237
J Biol Chem. 1995 Jun 9;270(23):14214-9
pubmed: 7775482
Mol Cell Biol. 1999 Jul;19(7):4798-805
pubmed: 10373529
Biochem J. 2016 May 15;473(10):1281-95
pubmed: 27208212
Cell. 2018 Apr 19;173(3):762-775.e16
pubmed: 29677517
J Am Heart Assoc. 2018 Jan 30;7(3):
pubmed: 29382667
Am J Physiol Gastrointest Liver Physiol. 2002 Jul;283(1):G204-11
pubmed: 12065308
J Clin Invest. 2005 Nov;115(11):3217-27
pubmed: 16239968
J Exp Med. 2018 Oct 1;215(10):2655-2672
pubmed: 30194266
Br J Pharmacol. 2019 Jan;176(2):189-196
pubmed: 30341769
J Virol. 2011 Dec;85(23):12686-97
pubmed: 21917944
J Biol Chem. 1997 Dec 5;272(49):30969-74
pubmed: 9388244
Mol Biol Cell. 2006 Nov;17(11):4686-97
pubmed: 16928957
Circ Res. 2014 May 23;114(11):1684-9
pubmed: 24677271
Cell Cycle. 2017 Oct 18;16(20):1893-1901
pubmed: 28820314
Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1310-5
pubmed: 12171793
Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1535-43
pubmed: 19684185
Eur Heart J. 2014 Nov 14;35(43):3013-20, 3020a-3020d
pubmed: 25230814
J Biol Chem. 1998 Nov 13;273(46):30544-9
pubmed: 9804824
Am J Physiol. 1997 Aug;273(2 Pt 1):C572-8
pubmed: 9277354
Pflugers Arch. 2010 May;459(6):793-806
pubmed: 20012875
Nat Rev Mol Cell Biol. 2009 Jan;10(1):53-62
pubmed: 19197332
Am J Pathol. 2005 Aug;167(2):609-18
pubmed: 16049344
Annu Rev Biomed Eng. 2014 Jul 11;16:505-32
pubmed: 24905872
Pharmacol Rev. 2002 Jun;54(2):233-46
pubmed: 12037140
Biochemistry. 1997 Apr 15;36(15):4438-48
pubmed: 9109651
Peptides. 2010 Jun;31(6):1150-8
pubmed: 20332006
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2191-8
pubmed: 24876354
J Biol Chem. 1996 Aug 23;271(34):20828-35
pubmed: 8702838
Arterioscler Thromb Vasc Biol. 1999 Aug;19(8):1825-34
pubmed: 10446060
J Clin Invest. 2019 Jun 17;129(7):2775-2791
pubmed: 31205027
Dev Cell. 2012 Sep 11;23(3):600-10
pubmed: 22975328
Nat Rev Cardiol. 2020 Jan;17(1):52-63
pubmed: 31366922
Antioxid Redox Signal. 2016 Sep 1;25(7):373-88
pubmed: 27027326
Hum Gene Ther Methods. 2017 Oct;28(5):235-246
pubmed: 29048971
J Biol Chem. 2001 Jun 1;276(22):18934-40
pubmed: 11259436
J Cell Biol. 2005 Apr 11;169(1):191-202
pubmed: 15809308
Circ Res. 2016 Feb 19;118(4):535-46
pubmed: 26892956
J Biol Chem. 1986 Jan 25;261(3):989-92
pubmed: 3511044
J Clin Invest. 2015 Aug 3;125(8):3077-86
pubmed: 26168216
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15463-8
pubmed: 17030791
Antioxid Redox Signal. 2011 Sep 1;15(5):1405-14
pubmed: 21050140
Physiol Rev. 2011 Jan;91(1):327-87
pubmed: 21248169
Nat Rev Dis Primers. 2019 Aug 16;5(1):56
pubmed: 31420554
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):769-74
pubmed: 26733684
Nat Rev Cardiol. 2019 Jul;16(7):389-406
pubmed: 30846875
EMBO J. 2002 Dec 16;21(24):6791-800
pubmed: 12486000
Nature. 2005 Sep 15;437(7057):426-31
pubmed: 16163360
Nucleic Acids Res. 1996 Jun 15;24(12):2236-42
pubmed: 8710491